A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis

NCT07471048 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DIETARY_SUPPLEMENT: Oral supplement containing 200mg Magnolia officinalis bark extract
DIETARY_SUPPLEMENT: Placebo

Sponsor

Sirt3 LLC

Collaborators

[object Object]